Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
1.380
+0.040 (2.99%)
At close: May 19, 2025, 4:00 PM
1.340
-0.040 (-2.90%)
After-hours: May 19, 2025, 6:25 PM EDT
Repare Therapeutics Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Repare Therapeutics stock ranges from a low of $4.00 to a high of $5.00. The average analyst price target of $4.50 forecasts a 226.09% increase in the stock price over the next year.
Price Target: $4.50 (+226.09%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 7, 2025.
Analyst Ratings
The average analyst rating for Repare Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $5 | Strong Buy | Maintains | $10 → $5 | +262.32% | Mar 7, 2025 |
| LifeSci Capital | LifeSci Capital | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 13, 2024 |
| Stifel | Stifel | Strong Buy Maintains $9 → $4 | Strong Buy | Maintains | $9 → $4 | +189.86% | Dec 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +624.64% | Nov 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +624.64% | Oct 24, 2024 |
Financial Forecast
Revenue This Year
10.20M
from 53.48M
Decreased by -80.93%
Revenue Next Year
10.20M
from 10.20M
EPS This Year
-2.15
from -2.00
EPS Next Year
-1.78
from -2.15
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.0M | 21.0M | 60.6M | ||
| Avg | 10.2M | 10.2M | 29.4M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -60.7% | 105.9% | 494.0% | ||
| Avg | -80.9% | - | 188.5% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.21 | -1.83 | -2.47 |
| Avg | -2.15 | -1.78 | -2.40 |
| Low | -2.07 | -1.71 | -2.30 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.